Article Versions Notes

Takahashi-Ruiz L, Fermaintt CS, Wilkinson NJ, Chan PYW, Mooberry SL, Risinger AL. The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers. 2022; 14(23):5962. https://doi.org/10.3390/cancers14235962

Takahashi-Ruiz, Leila, Charles S. Fermaintt, Nancy J. Wilkinson, Peter Y. W. Chan, Susan L. Mooberry, and April L. Risinger. 2022. "The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models" Cancers 14, no. 23: 5962. https://doi.org/10.3390/cancers14235962

Takahashi-Ruiz, L., Fermaintt, C. S., Wilkinson, N. J., Chan, P. Y. W., Mooberry, S. L., & Risinger, A. L. (2022). The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers, 14(23), 5962. https://doi.org/10.3390/cancers14235962